Exagen Inc.
XGN
Revenue
15.06M
▲649.00k▲4.50%
3 Months ChangeAssets
49.31M
▼-1.50M▼-2.95%
3 Months ChangeLiabilities
31.72M
▲905.00k▲2.94%
3 Months ChangeFree Cash Flow
-9.13M
▲1.02M▲10.04%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-05
Form 10-Q
ID: 0001274737-24-000079
2024-08-05
Form 8-K
ID: 0001274737-24-000078
2024-08-02
Form 8-K
ID: 0001274737-24-000071
2024-06-11
Form 8-K
ID: 0001274737-24-000056
2024-05-13
Form 10-Q
ID: 0001274737-24-000048
2024-05-13
Form 8-K
ID: 0001274737-24-000045
2024-04-26
Form 8-K
ID: 0001274737-24-000030
2024-03-18
Form 8-K
ID: 0001274737-24-000019
2024-01-08
Form 8-K
ID: 0001274737-24-000006
2023-12-11
Form 8-K
ID: 0001274737-23-000116